Literature DB >> 2744013

DiGeorge syndrome with hypogammaglobulinaemia: a patient with excess suppressor T cell activity treated with fetal thymus transplantation.

M Mayumi1, H Kimata, Y Suehiro, S Hosoi, S Ito, Y Kuge, K Shinomiya, H Mikawa.   

Abstract

A male infant with DiGeorge syndrome had hypogammaglobulinaemia with a normal number of B cells. CD3(+) T cells were reduced and the CD4(+)/CD8(+) ratio was reversed. Proliferative responses of T cells to mitogens and to allogeneic cells were low. The pokeweed mitogen (PWM)-induced B cell differentiation assay revealed a higher than normal suppressor T cell activity. This suggests that some T cells had differentiated into functionally mature cells resulting in an imbalance of regulatory T cell functions and that excess suppressor activity might play a role in hypogammaglobulinaemia. Fetal thymus transplantation improved both cellular and humoral immunity. The patient's susceptibility to viral and bacterial infections, proliferative response of T cells and serum Ig concentration returned to normal. The excess suppressor activity seen before transplantation disappeared. Hypocalcaemia did not improve. These results show that fetal thymus transplantation was effective not only in reconstituting cellular immunity but also in normalizing the imbalance of regulatory T cell functions in this patient with DiGeorge syndrome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744013     DOI: 10.1007/bf00441546

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromide.

Authors:  M A Pellegrino; S Ferrone; M P Dierich; R A Reisfeld
Journal:  Clin Immunol Immunopathol       Date:  1975-01

2.  DiGeorge syndrome associated with combined immunodeficiency. Dissociation of phytohemagglutinin and mixed leukocyte culture responses.

Authors:  R A Gatti; J J Gershanik; A H Levkoff; W Wertelecki; R A Good
Journal:  J Pediatr       Date:  1972-11       Impact factor: 4.406

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Foetal thymic transplant in a case of Digeorge's syndrome.

Authors:  W W Cleveland; B J Fogel; W T Brown; H E Kay
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

5.  Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome).

Authors:  C S August; F S Rosen; R M Filler; C A Janeway; B Markowski; H E Kay
Journal:  Lancet       Date:  1968-12-07       Impact factor: 79.321

6.  T-cell deficiency in diGeorge syndrome.

Authors:  H W Lischner; D S Huff
Journal:  Birth Defects Orig Artic Ser       Date:  1975

7.  Effects of concanavalin A-induced cells on the proliferative response of T cells. Concanavalin A-induced suppressor and amplifier cells to the proliferative response of human T cells to trinitrophenyl-modified autologous lymphocytes.

Authors:  M Mayumi; T Yoshida; K Shinomiya; S I Nishikawa; T Hirata; T Izumi; H Mikawa
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

Review 8.  Maturation of B-cell differentiation ability and T-cell regulatory function in infancy and childhood.

Authors:  T Miyawaki; N Moriya; T Nagaoki; N Taniguchi
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

9.  Present and future status of thymus transplantation.

Authors:  R Hong
Journal:  Ann Clin Res       Date:  1981

10.  Studies on the clonal origin of human B cell leukemia using monoclonal anti-idiotype antibodies.

Authors:  M Mayumi; H Kubagawa; G A Omura; W E Gathings; J F Kearney; M D Cooper
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

View more
  7 in total

1.  Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly.

Authors:  Ales Janda; Petr Sedlacek; Manfred Hönig; Wilhelm Friedrich; Martin Champagne; Tadashi Matsumoto; Alain Fischer; Benedicte Neven; Audrey Contet; Danielle Bensoussan; Pierre Bordigoni; David Loeb; William Savage; Nada Jabado; Francisco A Bonilla; Mary A Slatter; E Graham Davies; Andrew R Gennery
Journal:  Blood       Date:  2010-06-07       Impact factor: 22.113

2.  Hypogammaglobulinaemia in DiGeorge sequence.

Authors:  A Etzioni; S Pollack
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

3.  Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  K E Sullivan; D McDonald-McGinn; D A Driscoll; B S Emanuel; E H Zackai; A F Jawad
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+mice.

Authors:  N Hosaka; M Nose; M Kyogoku; N Nagata; S Miyashima; R A Good; S Ikehara
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

5.  Normalization of the peripheral blood T cell receptor V beta repertoire after cultured postnatal human thymic transplantation in DiGeorge syndrome.

Authors:  C M Davis; T M McLaughlin; T J Watson; R H Buckley; S E Schiff; L P Hale; B F Haynes; M L Markert
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

6.  Post-natal ontogenesis of the T-cell receptor CD4 and CD8 Vbeta repertoire and immune function in children with DiGeorge syndrome.

Authors:  Caterina Cancrini; Maria Luisa Romiti; Andrea Finocchi; Silvia Di Cesare; Patrizia Ciaffi; Claudia Capponi; Savita Pahwa; Paolo Rossi
Journal:  J Clin Immunol       Date:  2005-05       Impact factor: 8.542

7.  Clinical and molecular cytogenetic studies of an unrecognised 22q11.2 deletion in three families.

Authors:  Linhuan Huang; Yingjun Xie; Yi Zhou; Yanmin Luo; Xuan Huang; Zhe Xu; Danlei Cai; Qun Fang
Journal:  Exp Ther Med       Date:  2015-01-21       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.